In order to develop a new class of revolutionary medications for patients, Moderna is developing the science of messenger RNA (mRNA).

mRNA medications are intended to instruct the body’s cells to create intracellular, membrane, or secreted proteins that may be useful for therapeutic or preventive purposes and may be used to treat a variety of illnesses. With the help of Moderna’s platform, which is built on ongoing developments in basic and applied mRNA science, delivery technology, and manufacturing, the Company is able to explore a strong pipeline of fresh development candidates concurrently. For infectious diseases, immuno-oncology, uncommon diseases, cardiovascular disorders, autoimmune and inflammatory diseases, Moderna is independently and with strategic partners developing medicines and vaccines.